Moseley Investment Management Inc. Sells 49 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Moseley Investment Management Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,532 shares of the healthcare conglomerate’s stock after selling 49 shares during the quarter. Moseley Investment Management Inc.’s holdings in UnitedHealth Group were worth $1,281,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of UnitedHealth Group by 26.2% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 4,118 shares of the healthcare conglomerate’s stock valued at $2,083,000 after acquiring an additional 854 shares during the last quarter. Park Avenue Securities LLC raised its holdings in shares of UnitedHealth Group by 4.6% during the 4th quarter. Park Avenue Securities LLC now owns 32,034 shares of the healthcare conglomerate’s stock valued at $16,205,000 after buying an additional 1,412 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in UnitedHealth Group by 89.3% in the fourth quarter. Assenagon Asset Management S.A. now owns 702,722 shares of the healthcare conglomerate’s stock worth $355,479,000 after buying an additional 331,539 shares in the last quarter. Board of the Pension Protection Fund purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $759,000. Finally, Rockland Trust Co. boosted its stake in shares of UnitedHealth Group by 1.9% in the 4th quarter. Rockland Trust Co. now owns 79,442 shares of the healthcare conglomerate’s stock valued at $40,187,000 after purchasing an additional 1,461 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $543.76 on Wednesday. The business has a fifty day simple moving average of $554.45 and a two-hundred day simple moving average of $563.12. The firm has a market capitalization of $500.41 billion, a P/E ratio of 35.42, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the company earned $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UNH. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.